Biocryst Pharmaceuticals (BCRX) Profit After Tax: 2010-2015
Historic Profit After Tax for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to -$14.6 million.
- Biocryst Pharmaceuticals' Profit After Tax fell 67.46% to -$14.6 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$36.6 million, marking a year-over-year increase of 6.14%. This contributed to the annual value of -$45.2 million for FY2014, which is 50.09% down from last year.
- Latest data reveals that Biocryst Pharmaceuticals reported Profit After Tax of -$14.6 million as of Q3 2015, which was down 398.33% from $4.9 million recorded in Q2 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Profit After Tax peaked at $4.9 million during Q2 2015, and registered a low of -$15.2 million during Q1 2015.
- Moreover, its 3-year median value for Profit After Tax was -$10.1 million (2014), whereas its average is -$9.1 million.
- Per our database at Business Quant, Biocryst Pharmaceuticals' Profit After Tax slumped by 124.97% in 2014 and then soared by 133.46% in 2015.
- Biocryst Pharmaceuticals' Profit After Tax (Quarterly) stood at -$13.2 million in 2011, then grew by 16.21% to -$11.1 million in 2012, then skyrocketed by 50.88% to -$5.4 million in 2013, then crashed by 114.99% to -$11.7 million in 2014, then crashed by 67.46% to -$14.6 million in 2015.
- Its last three reported values are -$14.6 million in Q3 2015, $4.9 million for Q2 2015, and -$15.2 million during Q1 2015.